Prediction of Ventricular Arrhythmias by QRS/QTc - Ratio in Citalopram or Escitalopram Intoxication
BackgroundThe U.S. Food and Drug Administration (FDA) has stated that citalopram and escitalopram should not be used at daily doses above 40 mg/20 mg due to risk for development of fatal ventricular arrhythmias like torsade de pointes (TdP). Yet, supratherapeutic serum concentrations of citalopram a...
| Autori principali: | , |
|---|---|
| Natura: | Articolo |
| Lingua: | English |
| Pubblicazione: |
Frontiers Media S.A.
2022-03-01
|
| Serie: | Frontiers in Medicine |
| Soggetti: | |
| Accesso online: | https://www.frontiersin.org/articles/10.3389/fmed.2022.866454/full |